Cas no 855763-24-5 (4,5,8-trichloroquinoline)
4,5,8-trichloroquinoline Chemical and Physical Properties
Names and Identifiers
-
- 4,5,8-trichloroquinoline
- 4,5,8-Trichlor-chinolin
- 4,5,8-trichloro-quinoline
- CS-0312727
- W16860
- ZB0111
- DTXSID30589015
- MFCD09787693
- AB52003
- AS-58262
- 855763-24-5
- DB-357650
- AKOS009580856
-
- MDL: MFCD09787693
- Inchi: 1S/C9H4Cl3N/c10-5-1-2-7(12)9-8(5)6(11)3-4-13-9/h1-4H
- InChI Key: YHGCMJPZRPMARL-UHFFFAOYSA-N
- SMILES: ClC1=CC=C(C2C1=C(C=CN=2)Cl)Cl
Computed Properties
- Exact Mass: 230.94100
- Monoisotopic Mass: 230.940932g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 1
- Heavy Atom Count: 13
- Rotatable Bond Count: 0
- Complexity: 188
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 4.1
- Topological Polar Surface Area: 12.9?2
Experimental Properties
- PSA: 12.89000
- LogP: 4.19500
4,5,8-trichloroquinoline Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Chemenu | CM246850-1g |
4,5,8-Trichloroquinoline |
855763-24-5 | 97% | 1g |
$355 | 2021-08-04 | |
| Alichem | A189004327-1g |
4,5,8-Trichloroquinoline |
855763-24-5 | 97% | 1g |
$391.40 | 2023-08-31 | |
| Apollo Scientific | OR183471-250mg |
4,5,8-Trichloroquinoline |
855763-24-5 | 250mg |
£98.00 | 2025-02-19 | ||
| Apollo Scientific | OR183471-1g |
4,5,8-Trichloroquinoline |
855763-24-5 | 1g |
£320.00 | 2025-02-19 | ||
| Chemenu | CM246850-1g |
4,5,8-Trichloroquinoline |
855763-24-5 | 97% | 1g |
$430 | 2022-06-10 | |
| eNovation Chemicals LLC | D957031-100mg |
4,5,8-Trichloroquinoline |
855763-24-5 | 95% | 100mg |
$185 | 2024-06-07 | |
| eNovation Chemicals LLC | D957031-250mg |
4,5,8-Trichloroquinoline |
855763-24-5 | 95% | 250mg |
$270 | 2024-06-07 | |
| 1PlusChem | 1P0052ML-500mg |
4,5,8-Trichloroquinoline |
855763-24-5 | 95% | 500mg |
$320.00 | 2024-04-21 | |
| Aaron | AR0052UX-100mg |
4,5,8-Trichloroquinoline |
855763-24-5 | 95% | 100mg |
$154.00 | 2023-12-13 | |
| Aaron | AR0052UX-250mg |
4,5,8-Trichloroquinoline |
855763-24-5 | 95% | 250mg |
$242.00 | 2023-12-13 |
4,5,8-trichloroquinoline Related Literature
-
Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
-
Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003
-
Robert J. Meagher,Anson V. Hatch,Ronald F. Renzi,Anup K. Singh Lab Chip, 2008,8, 2046-2053
-
Yaqing Liu,Jiangtao Ren,Jing Li,Jiyang Liu,Erkang Wang Chem. Commun., 2012,48, 802-804
Additional information on 4,5,8-trichloroquinoline
Chemical Profile of 4,5,8-trichloroquinoline (CAS No. 855763-24-5)
4,5,8-trichloroquinoline, identified by its Chemical Abstracts Service (CAS) number 855763-24-5, is a halogenated derivative of quinoline, a heterocyclic aromatic compound with significant relevance in medicinal chemistry and material science. This compound features three chlorine substituents strategically positioned at the 4, 5, and 8 positions of the quinoline ring, which imparts unique electronic and steric properties essential for its diverse applications.
The molecular structure of 4,5,8-trichloroquinoline consists of a benzene-like quinoline core substituted with chlorine atoms. This structural motif enhances its reactivity and binding affinity, making it a valuable intermediate in the synthesis of various pharmacologically active molecules. The presence of multiple chlorine atoms increases the compound's lipophilicity and potential for metabolic stability, which are critical factors in drug design.
In recent years, 4,5,8-trichloroquinoline has garnered attention in the field of medicinal chemistry due to its versatile pharmacological profile. Researchers have explored its potential as a scaffold for developing novel therapeutic agents targeting a range of diseases. Notably, studies have highlighted its antimicrobial and anti-inflammatory properties, making it a promising candidate for treating infections and chronic inflammatory conditions.
One of the most compelling aspects of 4,5,8-trichloroquinoline is its role in the synthesis of bioactive molecules with enhanced biological activity. For instance, derivatives of this compound have been investigated for their ability to modulate enzyme activity and receptor binding. The halogenated quinoline core serves as a key pharmacophore, contributing to the compound's interactions with biological targets such as kinases and transcription factors.
Recent advancements in computational chemistry have further elucidated the mechanistic insights into how 4,5,8-trichloroquinoline interacts with biological systems. Molecular modeling studies suggest that the chlorine substituents enhance binding affinity by improving hydrophobic interactions and electrostatic complementarity with target proteins. These findings have guided the development of more potent and selective analogs with improved pharmacokinetic profiles.
The synthesis of 4,5,8-trichloroquinoline involves multi-step organic reactions that require precise control over reaction conditions to achieve high yields and purity. Common synthetic routes include chlorination of quinoline precursors followed by regioselective functionalization. The use of advanced catalytic systems has enabled more efficient and sustainable production methods, reducing waste and energy consumption.
Industrial applications of 4,5,8-trichloroquinoline extend beyond pharmaceuticals into materials science. The compound's unique electronic properties make it suitable for use in organic electronics and optoelectronic devices. Researchers have explored its potential as a component in light-emitting diodes (LEDs) and photovoltaic cells due to its ability to absorb light across a broad spectrum.
The environmental impact of 4,5,8-trichloroquinoline is another area of growing interest. While the compound offers numerous benefits in chemical synthesis and drug development, its halogenated nature raises questions about its biodegradability and potential environmental persistence. Efforts are underway to develop greener synthetic methods that minimize hazardous byproducts and reduce ecological footprints.
Future research directions for 4,5,8-trichloroquinoline include exploring its role in emerging therapeutic areas such as oncology and neurodegenerative diseases. Preclinical studies have shown promising results in using derivatives of this compound to inhibit tumor growth and protect against neurotoxicity. These findings underscore the need for further investigation into its mechanisms of action and potential clinical applications.
In conclusion,4,5,8-trichloroquinoline (CAS No. 855763-24-5) is a multifaceted compound with significant implications in pharmaceuticals and materials science. Its unique structural features make it an invaluable tool for developing novel therapeutics and advanced materials. As research continues to uncover new applications for this compound,4,5,8-trichloroquinoline, it will undoubtedly play an increasingly important role in addressing global challenges in medicine and technology.
855763-24-5 (4,5,8-trichloroquinoline) Related Products
- 703-66-2(6,8-Dichloroquinoline)
- 25771-77-1(3,4,8-trichloroquinoline)
- 25771-78-2(3,4,6,8-Tetrachloroquinoline)
- 10166-44-6(Acridine, 4,9-dichloro-)
- 25836-11-7(3,4-Dichloroquinoline)
- 96129-73-6(4,7-Dichloro-1H-indole)
- 21617-12-9(4,8-Dichloroquinoline)
- 611-33-6(8-Chloroquinoline)
- 28814-25-7(Acridine, 4-chloro-)
- 17999-80-3(4,7,8-TRICHLOROQUINOLINE)